Communication 2021 4

Preclinical study of Targeted Alpha Therapy using 211At-labeled phenylalaline derivative in a syngeneic Multiple Myeloma model OP-0106.
Gaschet J, Echeynne R, Chouin N, Gazzola S, Guérard F, Gouard S, Marionnaud-Lambot S, Maubert AL, Alliot C, Hofgaard PO, Bogen B, Yan E, Haddad F, Kraeber-Bodéré F, Wheatcroft M, Gestin JF, Chérel M
EANM’21 34th Annual congress of the European Association of Nuclear Medicine, virtual edition, October 20-23 2021